Michael Schotsaert
@mschotsaert.bsky.social
My lab studies virus-host interactions - focus on both innate and adaptive immunity - MPXV/flu/SARS-CoV-2 - Vaccines/Adjuvants
Congrats to Lauren A. Chang to bring this home and thanks to all the coauthors Brett T. Webb @yeungadventures.bsky.social T. Yeung (master of 🔬 ) Moataz Noureddine Prajakta Warang Gagandeep Singh Eleanor Burgess for their support and wonderful collaboration. More to come soon!
November 7, 2025 at 6:42 PM
Congrats to Lauren A. Chang to bring this home and thanks to all the coauthors Brett T. Webb @yeungadventures.bsky.social T. Yeung (master of 🔬 ) Moataz Noureddine Prajakta Warang Gagandeep Singh Eleanor Burgess for their support and wonderful collaboration. More to come soon!
Reposted by Michael Schotsaert
✨ In collaboration with Ian Wilson, Bernie Moss, @carolilucas.bsky.social, @mschotsaert.bsky.social @vivianasimonlab.bsky.social, that’s exactly what we did!
We now have highly potent A35 human mAbs, in vitro and in vivo. They are protective both before and after mouse infection.
[4/9]
We now have highly potent A35 human mAbs, in vitro and in vivo. They are protective both before and after mouse infection.
[4/9]
August 26, 2025 at 3:29 PM
✨ In collaboration with Ian Wilson, Bernie Moss, @carolilucas.bsky.social, @mschotsaert.bsky.social @vivianasimonlab.bsky.social, that’s exactly what we did!
We now have highly potent A35 human mAbs, in vitro and in vivo. They are protective both before and after mouse infection.
[4/9]
We now have highly potent A35 human mAbs, in vitro and in vivo. They are protective both before and after mouse infection.
[4/9]
Inderdaad. Herzele.
July 6, 2025 at 9:48 PM
Inderdaad. Herzele.